Cyclophosphamide
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Botulinum toxin
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Ifosfamide
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Clonazepam/phenobarbital
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Carboplatin/gemcitabine
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Isavuconazole
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Ibrutinib
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Insulin
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Propafenone
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Enoxaparin-sodium
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Cetuximab
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Thalidomide
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Natalizumab
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Aspirin/unspecified anticoagulants
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Methotrexate
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Tacrolimus
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Brigatinib
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Alemtuzumab
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Tamoxifen
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Heparin
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Cyclophosphamide
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Botulinum toxin
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Clonazepam/phenobarbital
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Ibrutinib
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Insulin
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Propafenone
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Enoxaparin-sodium
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Methotrexate
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Tacrolimus
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Cladribine
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Pembrolizumab
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Carboplatin/gemcitabine
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Cetuximab
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Thalidomide
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Natalizumab
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Alemtuzumab
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Potassium-chloride
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Aspirin
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Aspirin/unspecified anticoagulants
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Brigatinib
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Antineoplastics
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Atezolizumab
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Bendamustine/brentuximab-vedotin
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Warfarin
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Nivolumab
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Methotrexate
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Medsafe advises prescribing nitrofurantion by brand to avoid errors
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Nintedanib associated with proteinuria
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Isavuconazole
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research

Tamoxifen
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2021 Category: Drugs & Pharmacology Source Type: research